Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy-Reference-Cited by-同舟云学术

Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy

Published:2024-07-05 Issue:28 Volume:24 Page:8723-8731
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Xu Rui¹²³,Liu Xiangya¹²³,Zhang Yuxuan²³,Wu Guo¹²³,Huang Linzhuo²³,Li Rong¹,Xu Xiaoding¹²³^ORCID

Affiliation:

1. Department of Pharmacy and Pharmacology and the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, P. R. China

2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China

3. Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China

Funder

Guangdong Provincial Department of Science and Technology

Natural Science Foundation of Hunan Province

Guangzhou Municipal Science and Technology Bureau

National Natural Science Foundation of China

Key Research and Development Program of Hunan Province of China

Sun Yat-Sen Memorial Hospital

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.4c02139

Reference43 articles.

1. The foundations of immune checkpoint blockade and the ipilimumab approval decennial

2. The blockade of immune checkpoints in cancer immunotherapy

3. A guide to cancer immunotherapy: from T cell basic science to clinical practice

4. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

5. Immune Checkpoint Inhibitors: Basics and Challenges